One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2020-136640
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 3 |
Affiliation: Bristol-Myers Squibb (United States), Medical City Dallas Hospital, Texas Oncology, Atlantic Health System, Centennial Medical Center, Sarah Cannon, Cancer Center of Kansas, Oncology Hematology Care, Providence Portland Medical Center, Prisma Health, Colorado Blood Cancer Institute, Norton Healthcare, Intermountain Healthcare, AdventHealth OrlandoOutcomes of Treatment with the Chimeric Antigen Receptor (CAR) T Cell Therapy Lisocabtagene Maraleucel (liso-cel) in the Nonuniversity Setting: Initial Results from the Outreach Study
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
